# A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy

> **NCT04873232** · PHASE3 · COMPLETED · sponsor: **Helixmith Co., Ltd.** · enrollment: 106 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **BIOLOGICAL:** Engensis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04873232
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-17
- **Primary completion:** 2023-09-14
- **Final completion:** 2024-07-23
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873232, "A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04873232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*